We’re inspired by the patients, caregivers, and family members on the front lines of the fight against neurodegenerative diseases. While it’s our mission to one day end the suffering caused by these diseases, we’d like to connect you with resources, help, and information along the way. Get started by clicking one of the links below.



About the Centaur Trial

The CENTAUR trial of AMX0035 was a 24-week, randomized, double-blind, placebo-controlled Phase II clinical trial completed in late 2019, which demonstrated statistically significant treatment benefits for people with ALS.

Learn More

Alzheimer’s Disease

About the Pegasus Trial

Amylyx’s therapeutic candidate AMX0035 is currently undergoing evaluation as a potential disease-modifying treatment for Alzheimer’s disease in the Pegasus trial, supported by the Alzheimer’s Association, the Alzheimer’s Drug Discovery Foundation and the Cure Alzheimer’s Fund.

Learn More


For inquiries or further information, please do not hesitate to contact us. 

Contact Us